Beruflich Dokumente
Kultur Dokumente
Ménière’s
disease
A stepwise approach
MELVILLE DA CRUZ FRACS, MSc, MD
M
typically accompanied by an énière’s disease is characterised by CLINICAL FEATURES AND NATURAL
intense sensation of move recurrent attacks of vertigo accom- HISTORY
ment, nausea, vomiting, panied by fluctuating sensorineural The hallmark of an acute Ménière’s attack is
diarrhoea and sweating, and hearing loss, tinnitus and a sense of prolonged vertigo. The vertigo is characterised
can last hours. aural fullness. Prosper Ménière in 1861 cor- by a sudden unheralded intense sensation of
• Treatment options for acute rectly attributed the attacks to a disorder of the movement, most commonly rotation or spinning,
attacks include ondansetron, inner ear, suggesting that the mechanism of lasting at least 20 minutes and accompanied by
prochlorperazine and causation could be similar to migraine or inner nausea, vomiting, diarrhoea and sweating. The
diazepam. ear vasospasm, a differential diagnosis which duration and character of the vertigo is impor-
• In most patients, attack is still relevant for the disease today.1 tant in the diagnosis of Ménière’s disease
frequency and severity can because episodes lasting a few seconds or min-
be reduced by a stepwise MÉNIÈRE’S DISEASE TODAY utes are more likely to be due to benign parox-
approach of dietary restriction The differential diagnosis of vertigo is broad, ysmal positional vertigo (BPPV) or, if longer
of sodium, lifestyle changes often leading to all cases of vertigo being labelled than eight to 12 hours, to vestibular n
euritis or
and medication; surgical as Ménière’s disease. To clarify the diagnosis, cerebellar stroke. Feelings of light-headedness,
treatment is rarely required. treatment and prognostication of patients with pressure or vague disturbances of balance are
• Referral to a specialist is Ménière’s disease, the American Academy of more likely to be due to non-otological causes,
best for initial diagnosis and Otolaryngology – Head and Neck Surgery such as postural hypotension, hyperglycaemia,
evaluation. (AAO-HNS) has published guidelines for the hyperventilation, panic attacks or anxiety.
• GPs have an important role classification of Ménière’s disease (Box 1).2 In the early stages of Ménière’s disease,
in ongoing management of Although the category of ‘certain Ménière’s patients may report only the vertigo symptoms,
patients with Ménière’s disease’ is used only as a research definition, as as the fluctuations in hearing thresholds are
disease. it requires postmortem histological examina- minor and may go unnoticed. However, as the
tion of the temporal bone, the other categories disease progresses the fluctuating hearing loss
are clinically useful. (generally affecting low tones) becomes more
Associate
Copyright _Layout Professor
1 17/01/12 1:43da
PMCruz is an4Ear Nose and Throat Surgeon at Westmead Hospital, University of Sydney, and a
Page
Cochlear Implant Surgeon at Sydney Cochlear Implant Centre, Sydney, NSW.
Downloaded for personal use only. No other uses permitted without permission. © MedicineToday 2014.
1. CLASSIFICATION OF MÉNIÈRE’S
DISEASE BASED ON AAO-HNS
CRITERIA 2*
Downloaded for personal use only. No other uses permitted without permission. © MedicineToday 2014.
because of the unpleasant sensation of ver- First test Second test
Figure 2. Serial
Air conduction
tigo. They may be sweaty and pale, unable pure tone
Bone conduction [ [
to stand up safely, nauseated and violently audiograms of
vomiting. There may be horizontal nystag- 0 [ [ [ the right ear in a
mus that changes direction as the attack
progresses. Following an attack, patients [ [ [ [ patient with uni
Downloaded for personal use only. No other uses permitted without permission. © MedicineToday 2014.
Ménière’s disease CONTINUED
Downloaded for personal use only. No other uses permitted without permission. © MedicineToday 2014.
widespread use of diuretics, a recent Hearing aids and tinnitus inner ear from a portable pressure gener-
Cochrane review found that there is no good management ator. Its use is based on the observation that
evidence to support or reject their use in Later in the course of Ménière’s disease, pressure changes applied to the inner ear
patients with Ménière’s disease.9 hearing loss starts to become intrusive. result in improved vertigo control in
Unilateral hearing loss has limited impact patients with Ménière’s disease. A standard
Betahistine in quiet listening environments but ventilation tube (or pre-existing perforation
Vascular insufficiency to the inner ear has becomes significant with background of the ear drum) is required for a micro-
long been proposed as a mechanism for noise. Directional hearing and music pressure device to be used. A treatment
Ménière’s disease. Betahistine (a histamine appreciation are also impaired. Bilateral cycle takes a few minutes and is repeated
analogue) has been used in this context for hearing loss in bilateral Ménière’s disease three times a day. Several studies have sug-
decades with the aim of improving inner is more intrusive. Hearing aids can be use- gested beneficial vertigo control with min-
ear perfusion. Testing in animals suggests ful in this situation, but a particular chal- imal risk of complications.
that this improves blood flow in the stria lenge is the fluctuating hearing loss seen
vascularis of the cochlear duct. A recent in Ménière’s disease. This has been partially Aminoglycoside treatment
clinical trial in humans showed betahistine addressed with self-programming and For patients in whom disabling vertigo
to be useful in reducing the frequency and adjustable hearing aids, which allow continues to be the dominant symptom
severity of vertiginous episodes and to some patients to adjust the power and processing despite reasonable trials of medical man-
degree in helping tinnitus. There was no setting of the hearing aid to suit their cur- agement, chemical labyrinthectomy should
effect on hearing loss or aural fullness. rent hearing thresholds. If hearing loss is be considered. Gentamicin is the most
Betahistine has minimal side effects severe then cochlear implants are highly commonly used ototoxic agent. The aim
(gastric irritation) and the dose is easily effective in restoring hearing.10 of treatment is to greatly reduce hair cell
varied (8 to 32 mg/day), allowing it to be Tinnitus can be a particularly distress- function in the vestibular system of the
titrated against the frequency and severity ing symptom. Management strategies affected ear. Gentamicin is relatively ves-
of vertiginous attacks. An initial regimen include education, sound therapy, short- tibulotoxic but leaves the cochlear hair cells
of 16 mg twice daily is a useful starting term drug therapy with benzodiazepines intact, making it suitable for treatment of
point, with the dose reduced by half each or sedating antidepressants, tinnitus intractable vertigo in ears with functional
month. There is very little interaction with retraining therapy and cognitive behav- hearing. Gentamicin can be administered
other medications, making it safe for use ioural therapy.11 under local anaesthesia by a transtympanic
in older patients with Ménière’s disease. injection or via a grommet to the affected
Semi-invasive and surgical ear, thereby sparing toxicity to the unaf-
Corticosteroids treatments fected ear in unilateral disease or the inac-
Corticosteroid treatments for Ménière’s Grommets tive ear in bilateral disease.
disease are a more recent intervention, based Several nonevidence-based surgical oper- A commonly used fixed-dose transtym-
on the possible autoimmune basis of the ations and ‘sham’ procedures have been panic protocol involves a single injection
disease and recent experience with use of used in the past with some benefit, most of gentamicin (40 mg in a 2 mL solution)
intratympanic corticosteroids to treat sudden likely because of a strong placebo effect. to the middle ear, with a second injection
sensorineural hearing loss. In addition to Most have now become historical, but four weeks later if the vertiginous episodes
their possible immune-modulating effects, insertion of grommets (tympanostomy continue. Most outcome studies of gen-
corticosteroids are likely to influence the tubes) is still used and may have a benefit tamicin report greatly improved vertigo
sodium and fluid dynamics of the inner ear on vertigo control and aural fullness. As it control. The effect on the vestibular hair
through their mineralocorticoid properties, is a simple procedure able to be performed cells is permanent and irreversible, with a
making them a theoretically attractive treat- under local anaesthesia, is temporary and small risk of associated hearing loss.
ment. However, few clinical trials have inves- has a low risk of complications (persistent
tigated the use of corticosteroids for vertigo perforation, otorrhoea) grommet insertion Endolymphatic sac surgery,
control to date. It may be reasonable to is worth considering. labyrinthectomy and vestibular nerve
administer a short course of oral cortico section
steroids (prednisone 1 mg/kg/day for 10 days) Micropressure therapy Surgery on the endolymphatic sac has been
or to consider intratympanic injection Micropressure therapy is a minimally inva- a major treatment for intractable vertigo.
(dexamethasone 4 mg, single dose) for sive therapy for Ménière’s disease that uses However, more recent analysis of the out-
patients with Ménière’s disease_Layout
Copyright who experi- a soft
1 17/01/12 probe
1:43 PM inserted
Page 4 into the external ear comes of sac surgery have shown it to be
ence a sudden drop in hearing thresholds. canal. This delivers pressure pulses to the no better than placebo treatments (simple
Downloaded for personal use only. No other uses permitted without permission. © MedicineToday 2014.
MedicineToday 2014; 15(3): 18-26
Ménière’s disease
A stepwise approach
MELVILLE DA CRUZ FRACS, MSc, MD
REFERENCES
Downloaded for personal use only. No other uses permitted without permission. © MedicineToday 2014.